1-8 of 8
Joo-Hang Kim
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Study of the Efficacy and Safety of Ramucirumab in Combination with Osimertinib in Advanced T790M-positive EGFR-mutant Non–small Cell Lung Cancer

Available to Purchase
Helena A. Yu, Luis G. Paz-Ares, James Chih-Hsin Yang, Ki Hyeong Lee, Pilar Garrido, Keunchil Park, Joo-Hang Kim, Dae Ho Lee, Huzhang Mao, Sameera R. Wijayawardana, Ling Gao, Rebecca R. Hozak, Bo H. Chao, David Planchard
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (4): 992–1002.
https://doi.org/10.1158/1078-0432.CCR-20-1690
Published: 15 February 2021
View articletitled, Phase I Study of the Efficacy and Safety of Ramucirumab in Combination with Osimertinib in Advanced T790M-positive EGFR-mutant Non–small Cell Lung Cancer
Open the PDF for Phase I Study of the Efficacy and Safety of Ramucirumab in Combination with Osimertinib in Advanced T790M-positive EGFR-mutant Non–small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Tumor Microenvironment Remodeling by Intratumoral Oncolytic Vaccinia Virus Enhances the Efficacy of Immune-Checkpoint Blockade

Available to Purchase
Hong Jae Chon, Won Suk Lee, Hannah Yang, So Jung Kong, Na Keum Lee, Eun Sang Moon, Jiwon Choi, Eun Chun Han, Joo Hoon Kim, Joong Bae Ahn, Joo Hang Kim, Chan Kim
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (5): 1612–1623.
https://doi.org/10.1158/1078-0432.CCR-18-1932
Published: 01 March 2019
View articletitled, Tumor Microenvironment Remodeling by Intratumoral Oncolytic Vaccinia Virus Enhances the Efficacy of Immune-Checkpoint Blockade
Open the PDF for Tumor Microenvironment Remodeling by Intratumoral Oncolytic Vaccinia Virus Enhances the Efficacy of Immune-Checkpoint Blockade in another window
Includes: Supplementary data
Journal Articles

Phase II Clinical and Exploratory Biomarker Study of Dacomitinib in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck

Available to Purchase
Han Sang Kim, Hyeong Ju Kwon, Inkyung Jung, Mi Ran Yun, Myung-Ju Ahn, Byung Woog Kang, Jong-Mu Sun, Sung Bae Kim, Dok-Hyun Yoon, Keon Uk Park, Se-Hoon Lee, Yoon Woo Koh, Se Hun Kim, Eun Chang Choi, Dong Hoe Koo, Jin Hee Sohn, Bomi Kim, Nak-Jung Kwon, Hwan Jung Yun, Min Goo Lee, Ji Hyun Lee, Tae-Min Kim, Hye Ryun Kim, Joo Hang Kim, Soonmyung Paik, Byoung Chul Cho
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (3): 544–552.
https://doi.org/10.1158/1078-0432.CCR-14-1756
Published: 01 February 2015
View articletitled, Phase II Clinical and Exploratory Biomarker Study of Dacomitinib in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck
Open the PDF for Phase II Clinical and Exploratory Biomarker Study of Dacomitinib in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck in another window
Includes: Supplementary data
Journal Articles

High EGFR Gene Copy Number and Skin Rash as Predictive Markers for EGFR Tyrosine Kinase Inhibitors in Patients with Advanced Squamous Cell Lung Carcinoma

Available to Purchase
Youngjoo Lee, Hyo Sup Shim, Moo Suk Park, Joo-Hang Kim, Sang-Jun Ha, Se Hoon Kim, Byoung Chul Cho
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (6): 1760–1768.
https://doi.org/10.1158/1078-0432.CCR-11-2582
Published: 14 March 2012
View articletitled, High EGFR Gene Copy Number and Skin Rash as Predictive Markers for EGFR Tyrosine Kinase Inhibitors in Patients with Advanced Squamous Cell Lung Carcinoma
Open the PDF for High EGFR Gene Copy Number and Skin Rash as Predictive Markers for EGFR Tyrosine Kinase Inhibitors in Patients with Advanced Squamous Cell Lung Carcinoma in another window
Journal Articles

Abstract B11: EGFR polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKI

Free
Minkyu Jung, Chul Ho Lee, Hyung Soon Park, Ji Hyun Lee, Joo Hang Kim, Young Ae Kang, Se Kyu Kim, Joon Chang, Dae Jun Kim, Byoung Chul Cho
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (3_Supplement): B11.
https://doi.org/10.1158/1078-0432.12AACRIASLC-B11
Published: 01 February 2012
View articletitled, Abstract B11: EGFR polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKI
Open the PDF for Abstract B11: EGFR polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKI in another window
Journal Articles

Randomized Phase III Trial of Gefitinib versus Docetaxel in Non–Small Cell Lung Cancer Patients Who Have Previously Received Platinum-Based Chemotherapy

Available to Purchase
Dae Ho Lee, Keunchil Park, Joo Hang Kim, Jong-Seok Lee, Sang Won Shin, Jin-Hyoung Kang, Myung-Ju Ahn, Jin Seok Ahn, Cheolwon Suh, Sang-We Kim
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (4): 1307–1314.
https://doi.org/10.1158/1078-0432.CCR-09-1903
Published: 15 February 2010
View articletitled, Randomized Phase III Trial of Gefitinib versus Docetaxel in Non–Small Cell Lung Cancer Patients Who Have Previously Received Platinum-Based Chemotherapy
Open the PDF for Randomized Phase III Trial of Gefitinib versus Docetaxel in Non–Small Cell Lung Cancer Patients Who Have Previously Received Platinum-Based Chemotherapy in another window
Journal Articles

High Tumor Metabolic Activity as Measured by Fluorodeoxyglucose Positron Emission Tomography Is Associated with Poor Prognosis in Limited and Extensive Stage Small-Cell Lung Cancer

Available to Purchase
Young Joo Lee, Arthur Cho, Byoung Chul Cho, Mijin Yun, Se Kyu Kim, Joon Chang, Jin Wook Moon, In Kyu Park, Hye Jin Choi, Joo-Hang Kim
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (7): 2426–2432.
https://doi.org/10.1158/1078-0432.CCR-08-2258
Published: 01 April 2009
View articletitled, High Tumor Metabolic Activity as Measured by Fluorodeoxyglucose Positron Emission Tomography Is Associated with Poor Prognosis in Limited and Extensive Stage Small-Cell Lung Cancer
Open the PDF for High Tumor Metabolic Activity as Measured by Fluorodeoxyglucose Positron Emission Tomography Is Associated with Poor Prognosis in Limited and Extensive Stage Small-Cell Lung Cancer in another window
Journal Articles

Enhanced Antitumor Effect of Oncolytic Adenovirus Expressing Interleukin-12 and B7-1 in an Immunocompetent Murine Model

Available to Purchase
Young-Sook Lee, Joo-Hang Kim, Kyung-Ju Choi, Il-Kyu Choi, Hoguen Kim, Sungae Cho, Byoung Chul Cho, Chae-Ok Yun
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (19): 5859–5868.
https://doi.org/10.1158/1078-0432.CCR-06-0935
Published: 04 October 2006
View articletitled, Enhanced Antitumor Effect of Oncolytic Adenovirus Expressing Interleukin-12 and B7-1 in an Immunocompetent Murine Model
Open the PDF for Enhanced Antitumor Effect of Oncolytic Adenovirus Expressing Interleukin-12 and B7-1 in an Immunocompetent Murine Model in another window